These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 3715788)
1. Antithrombin III Alger: a new homozygous AT III variant. Fischer AM; Cornu P; Sternberg C; Mériane F; Dautzenberg MD; Chafa O; Beguin S; Desnos M Thromb Haemost; 1986 Apr; 55(2):218-21. PubMed ID: 3715788 [TBL] [Abstract][Full Text] [Related]
2. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto. Okajima K; Ueyama H; Hashimoto Y; Sasaki Y; Matsumoto K; Okabe H; Inoue M; Araki S; Takatsuki K Thromb Haemost; 1989 Feb; 61(1):20-4. PubMed ID: 2749590 [TBL] [Abstract][Full Text] [Related]
3. Homozygous variant of antithrombin III: AT III Fontainebleau. Boyer C; Wolf M; Vedrenne J; Meyer D; Larrieu MJ Thromb Haemost; 1986 Aug; 56(1):18-22. PubMed ID: 3775688 [TBL] [Abstract][Full Text] [Related]
4. Antithrombin III Geneva: a hereditary abnormal AT III with defective heparin cofactor activity. de Moerloose PA; Reber G; Vernet P; Minazio P; Bouvier CA Thromb Haemost; 1987 Apr; 57(2):154-7. PubMed ID: 3603409 [TBL] [Abstract][Full Text] [Related]
5. Antithrombin III "Northwick Park": a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity. Howarth DJ; Samson D; Stirling Y; Seghatchian MJ Thromb Haemost; 1985 Jun; 53(3):314-9. PubMed ID: 4049307 [TBL] [Abstract][Full Text] [Related]
6. Homozygous or compound heterozygous qualitative antithrombin III deficiency. Cucuianu M; Blaga S; Pop S; Olinic D; Olinic N; Colhon D; Cristea A Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):335-7. PubMed ID: 7971256 [TBL] [Abstract][Full Text] [Related]
7. Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding. Tripodi A; Krachmalnicoff A; Mannucci PM Thromb Haemost; 1986 Dec; 56(3):349-52. PubMed ID: 3563966 [TBL] [Abstract][Full Text] [Related]
8. AT III Barcelona: a familial quantitative-qualitative AT III deficiency. Grau E; Fontcuberta J; Félez J; de Diego I; Soto R; Rutllant ML Thromb Haemost; 1988 Feb; 59(1):13-7. PubMed ID: 3363529 [TBL] [Abstract][Full Text] [Related]
9. Antithrombin III Avranches, a new variant with defective serine-protease inhibition--comparison with antithrombin III Charleville. Aiach M; Roncato M; Chadeuf G; Dezellus P; Capron L; Fiessinger JN Thromb Haemost; 1988 Aug; 60(1):94-6. PubMed ID: 3187951 [TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding. Jørgensen M; Petersen LC; Thorsen S J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440 [TBL] [Abstract][Full Text] [Related]
11. Antithrombin III Kumamoto II; a single mutation at Arg393-His increased the affinity of antithrombin III for heparin. Okajima K; Abe H; Wagatsuma M; Okabe H; Takatsuki K Am J Hematol; 1995 Jan; 48(1):12-8. PubMed ID: 7832187 [TBL] [Abstract][Full Text] [Related]
12. Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver"). Sambrano JE; Jacobson LJ; Reeve EB; Manco-Johnson MJ; Hathaway WE J Clin Invest; 1986 Mar; 77(3):887-93. PubMed ID: 3512602 [TBL] [Abstract][Full Text] [Related]
13. Antithrombin III deficiency. Cucuianu M; Blaga S; Pop S; Olinic D; Olinic N; Colhon D; Cristea A Rom J Intern Med; 1994; 32(2):119-27. PubMed ID: 7920326 [TBL] [Abstract][Full Text] [Related]
14. Antithrombin III Padua: a "new" congenital antithrombin III abnormality with normal or near normal activity, normal antigen, abnormal migration and no thrombotic disease. Girolami A; Pengo V; Cappellato G; Vianello C; Procidano M; Cartei C Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(1):98-111. PubMed ID: 6192061 [TBL] [Abstract][Full Text] [Related]
15. Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect. De Stefano V; Leone G; De Carolis MP; Ferrelli R; De Carolis S; Pagano L; Tortorolo G; Bizzi B Thromb Haemost; 1987 Jun; 57(3):329-31. PubMed ID: 3660333 [TBL] [Abstract][Full Text] [Related]
16. Further investigations on antithrombin III in the plasmas of patients with the abnormality of antithrombin III Budapest. Sas G; Pepper DS; Cash JD Thromb Diath Haemorrh; 1975 Jun; 33(3):564-72. PubMed ID: 1154312 [TBL] [Abstract][Full Text] [Related]
17. Antithrombin III Toyama: a hereditary abnormal antithrombin III of a patient with recurrent thrombophlebitis. Sakuragawa N; Takahashi K; Kondo S; Koide T Thromb Res; 1983 Jul; 31(2):305-17. PubMed ID: 6636045 [TBL] [Abstract][Full Text] [Related]
19. Antithrombin III molecular variants with defective binding to heparin or to serine proteases: evidence of two different abnormal patterns identified by crossed immunoelectrofocusing. Leone G; De Stefano V; Ferrelli R; Teofili L; Tengborn L; Vahtera E; Bizzi B Thromb Haemost; 1988 Aug; 60(1):8-12. PubMed ID: 3187949 [TBL] [Abstract][Full Text] [Related]
20. Familial variant of antithrombin III (AT III Bligny, 47Arg to His) associated with protein C deficiency. Wolf M; Boyer-Neumann C; Molho-Sabatier P; Neumann C; Meyer D; Larrieu MJ Thromb Haemost; 1990 Apr; 63(2):215-9. PubMed ID: 2363123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]